Pharmafile Logo

Goffin Consultancy Ltd

We are a consultancy, set up in early 1999, specialising in health economic analysis and systematic reviews of clinical data. We may be relatively small but we have an unusual depth of experience of the pharmaceutical industry – and if we don’t know, we almost certainly know someone who does! We also have a wide medical expertise in all aspects of medical and regulatory affairs and are able to assist smaller companies directly or on behalf of Private Equity / Venture Capitol companies. Depending on the project, we can bring in experts in a variety of fields including: medical affairs; market research, surveys; strategic planning; sales; market commercialization.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Riding House, Bossingham Road, Stelling Minnis, Canterbury, Kent, CT4 6AZ, United Kingdom
+44 (0)122 7709220

 Latest Content from PMHub 

Creating a monster to distrupt the market and solve a chronic problem

ConvaTec launched AQUACEL Ag+ in 2014, a new class of dressing proven to disrupt and destroy biofilm. They came to us to help them position AQUACEL Ag+ as the solution...

Inspiring researchers to find the impossible with a next generation solution

Though BD is very well known within the immunology and flowcytometry space, there is low awareness that BD is the only brand with a true multiomics offering. BD wanted to...

Keeping the food industry safe with next level protection solutions

Thermo Fisher Scientific came to us when they needed to communicate their New Generation food production technologies.

Empowering the GP to help women feel the vagisil prohydrate difference

Vagisil were launching their first product available on prescription. It was a tough task to put Vagisil ProHydrate front of mind and turn GPs into advocates. That’s why they came...

Medscape Education Announces Virtual Conference Focused on Elevating Women’s Healthcare

Medscape Education announces a new virtual conference focused on equipping clinicians with the latest advances in women's health.

The Medscape Medical Affairs Difference

What is so different about Medscape Medical Affairs in this crowdedMedical Communications landscape?

Leveraging KOL insights to succeed in a data-driven world

For years, key opinion leaders (KOLs) have held a position of authority and respect amongst those working across the life science industry, be it a result of their expertise in...

MISSION CRITICAL: HOW PHARMA CAN HELP THE NHS IMPROVE CARE FOR OLDER PEOPLE

With around two-thirds of all hospital beds occupied by over-65s, the care of older patients has long been recognised as key to the sustainability of the NHS. So how is...

KOL Insights in a Digital World

Presented at Evidence Life Science’s Medical Affairs KOL Engagement & Insights Conference, November 17, 2021 with Christina L. Hoffman, MS, Global Head, Medscape Medical Affairs

Report: Reinventing product and portfolio value for the biopharmaceutical industry

Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...